Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Apotex Inc

02 2Auro Pharma Inc

03 2Aurobindo Pharma Limited

04 5Centocor

05 1Eqova

06 2JAMP PHARMA

07 42Janssen-Cilag

08 10Johnson & Johnson Innovative Medicine

09 1Laurus Labs

10 1National Pharma

11 1Sandoz B2B

12 6Tecnimede

13 3Teva Pharmaceutical Industries

14 2Unichem Laboratories Limited

15 2Zydus Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

CANAGLIFLOZIN

Brand Name : CANAGLIFLOZIN

Dosage Form : TABLET;ORAL

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 210449

Regulatory Info :

Registration Country : USA

blank

02

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

CANAGLIFLOZIN

Brand Name : CANAGLIFLOZIN

Dosage Form : TABLET;ORAL

Dosage Strength : 300MG

Packaging :

Approval Date :

Application Number : 210449

Regulatory Info :

Registration Country : USA

blank

03

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

CANAGLIFLOZIN

Brand Name : CANAGLIFLOZIN

Dosage Form : TABLET;ORAL

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 210386

Regulatory Info :

Registration Country : USA

blank

04

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

CANAGLIFLOZIN

Brand Name : CANAGLIFLOZIN

Dosage Form : TABLET;ORAL

Dosage Strength : 300MG

Packaging :

Approval Date :

Application Number : 210386

Regulatory Info :

Registration Country : USA

blank

05

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

CANAGLIFLOZIN

Brand Name : INVOKANA

Dosage Form : TABLET;ORAL

Dosage Strength : 100MG

Packaging :

Approval Date : 2013-03-29

Application Number : 204042

Regulatory Info : RX

Registration Country : USA

blank

06

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

CANAGLIFLOZIN

Brand Name : INVOKANA

Dosage Form : TABLET;ORAL

Dosage Strength : 300MG

Packaging :

Approval Date : 2013-03-29

Application Number : 204042

Regulatory Info : RX

Registration Country : USA

blank

07

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Brand Name : INVOKAMET

Dosage Form : TABLET;ORAL

Dosage Strength : 50MG;500MG

Packaging :

Approval Date : 2014-08-08

Application Number : 204353

Regulatory Info : RX

Registration Country : USA

blank

08

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Brand Name : INVOKAMET

Dosage Form : TABLET;ORAL

Dosage Strength : 50MG;1GM

Packaging :

Approval Date : 2014-08-08

Application Number : 204353

Regulatory Info : RX

Registration Country : USA

blank

09

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Brand Name : INVOKAMET

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG;500MG

Packaging :

Approval Date : 2014-08-08

Application Number : 204353

Regulatory Info : RX

Registration Country : USA

blank

10

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Brand Name : INVOKAMET

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG;1GM

Packaging :

Approval Date : 2014-08-08

Application Number : 204353

Regulatory Info : RX

Registration Country : USA

blank

11

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Brand Name : INVOKAMET XR

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG;500MG

Packaging :

Approval Date : 2016-09-20

Application Number : 205879

Regulatory Info : RX

Registration Country : USA

blank

12

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Brand Name : INVOKAMET XR

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 50MG;1GM

Packaging :

Approval Date : 2016-09-20

Application Number : 205879

Regulatory Info : RX

Registration Country : USA

blank

13

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Brand Name : INVOKAMET XR

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 150MG;500MG

Packaging :

Approval Date : 2016-09-20

Application Number : 205879

Regulatory Info : RX

Registration Country : USA

blank

14

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Brand Name : INVOKAMET XR

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 150MG;1GM

Packaging :

Approval Date : 2016-09-20

Application Number : 205879

Regulatory Info : RX

Registration Country : USA

blank

15

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

CANAGLIFLOZIN

Brand Name : CANAGLIFLOZIN

Dosage Form : TABLET;ORAL

Dosage Strength : 300MG

Packaging :

Approval Date :

Application Number : 210503

Regulatory Info :

Registration Country : USA

blank

16

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

CANAGLIFLOZIN

Brand Name : CANAGLIFLOZIN

Dosage Form : TABLET; ORAL

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 210297

Regulatory Info :

Registration Country : USA

blank

17

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

CANAGLIFLOZIN

Brand Name : CANAGLIFLOZIN

Dosage Form : TABLET; ORAL

Dosage Strength : 300mg

Packaging :

Approval Date :

Application Number : 210451

Regulatory Info :

Registration Country : USA

blank

18

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

Canagliflozin

Brand Name :

Dosage Form : Tablet

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

19

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

CANAGLIFLOZIN

Brand Name : CANAGLIFLOZIN

Dosage Form : TABLET;ORAL

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 210541

Regulatory Info :

Registration Country : USA

blank

20

BPI Europe
Not Confirmed
arrow
arrow
BPI Europe
Not Confirmed

CANAGLIFLOZIN

Brand Name : CANAGLIFLOZIN

Dosage Form : TABLET;ORAL

Dosage Strength : 300MG

Packaging :

Approval Date :

Application Number : 210541

Regulatory Info :

Registration Country : USA

blank